ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancer

Published:2022-10-08 Issue:19 Volume:14 Page:7941-7958
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Yu Pian¹²³⁴⁵,Luo Shifu⁶,Cai Jiaxin⁶,Li Jie¹²³⁴⁵,Peng Cong¹²³⁴⁵

Affiliation:

1. The Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410000, Hunan, China

2. National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Changsha 410000, Hunan, China

3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha 410000, Hunan, China

4. Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha 410000, Hunan, China

5. Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha 410000, Hunan, China

6. Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference40 articles.

1. Radical surgery of oligometastatic pancreatic cancer.;Büchler;Eur J Surg Oncol,2017

2. Pancreatic Cancer: A Review.;O’Reilly;JAMA,2021

3. Pancreatic cancer.;Shroff;Lancet,2020

4. Chemoresistance in Pancreatic Cancer.;Yang;Int J Mol Sci,2019

5. The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection.;Zhang;Mass Spectrom Rev,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of immune- and oxidative stress-related signature genes as potential targets for mRNA vaccines for pancreatic cancer patients;Medicine;2024-07-05

2. The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer;Cancer Medicine;2024-05

3. Transcriptome-wide association studies associated with Crohn’s disease: challenges and perspectives;Cell & Bioscience;2024-02-25

4. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer;Frontiers in Oncology;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3